Official websites use .gov
Secure .gov websites use HTTPS
« Previous
Next »
Titles
- A sense of déjà vu: the debate surrounding state biosimilar substitution laws1
- Brand name drug prices increase more than twice as fast as inflation in 20181
- Brand name prescription drug prices increase four times faster than inflation in 20171
- Closing the "doughnut hole" has helped protect millions of Medicare beneficiaries from high drug costs1
- Drug price increases that exceed inflation are costing Medicare Part D billions1
- Novel anticoagulants achieve rapid market penetration despite higher costs1
- Price decreases for widely used generic drugs slow in 2017 after two years of substantial price drops1
- Prices for top Medicare Part D drugs have more than tripled since entering the market1
- Reducing potential overuse of dementia drugs could lead to considerable savings1
- Rx price watch report: price growth for brand name and specialty drugs more than offset price decrease for generic drugs1
- Rx price watch report: specialty prescription drug prices continue to climb1
- State biosimilar substitution laws could reduce consumer access and savings1
- Trends in retail prices of brand name prescription drugs widely used by older Americans: 2006 to 20201
- Trends in retail prices of brand name prescription drugs widely used by older Americans: 2017 year-end update1
- Trends in retail prices of generic prescription drugs widely used by older Americans, 2006 to 20201
- Trends in retail prices of generic prescription drugs widely used by older Americans: 2017 year-end update1
- Trends in retail prices of prescription drugs widely used by older Americans: 2017 year-end update1
- Trends in retail prices of specialty prescription drugs widely used by older Americans, 2006 to 20201
- Trends in retail prices of specialty prescription drugs widely used by older Americans: 2017 year-end update1